Hospital Israelita Albert Einstein (HIAE), a 489-bed hospital in Sao Paulo, Brazil, has partnered with the University of Texas MD Anderson Cancer Center in a bid to address the cancer burden in Brazil.
The partnership, MD Anderson’s first in Latin America, will enable HIAE to make use of the practices, education, research and treatment protocols developed at MD Anderson.
Go deeper with GlobalData
As part of the partnership, MD Anderson will provide clinical care oversight, order sets, and treatment algorithm to HIAE.
The collaboration will help the Brazilian hospital achieve clinical and operational integration with MD Anderson across the entire cancer care continuum.
The clinical integration will include planning and clinical programme support, faculty and staff education and training, quality measurement and reporting tools, access to clinical trials and research collaborations.
MD Anderson president Ronald DePinho said: "Our mission and vision challenge us to be the single most impactful institution in relieving the burden of cancer globally, and we can achieve this by extending our brand of prevention, care, research and education to like-minded organisations worldwide.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData"Hospital Israelita Albert Einstein is recognised for its exceptional physicians, state-of-the-art facilities and high-quality care, and we’re combining their excellence with MD Anderson’s vast cancer expertise."
With the partnership, Latin American patients will have access to a multidisciplinary, multispeciality cancer centre with outpatient care, advanced treatment technologies and a range of support services all in one location.
The services will include medical, radiation and surgical oncology, as well as pathology, laboratory, diagnostic imaging and other supportive clinical services.
MD Anderson business development vice-president Amy Hay said: "Brazil has a cancer burden of over a half million cases a year.
"By expanding our collaboration with Latin America’s leading hospital, we intend to address that challenge by delivering advanced and research-driven multidisciplinary care.
"Together, we’re changing cancer care delivery in Brazil for the benefit of patients across the region."
Image: MD Anderson and Hospital Israelita Albert Einstein will work together to tackle the cancer burden in Brazil. Photo: courtesy of The University of Texas MD Anderson Cancer Center.
